Roundtable: Plan sponsor considerations around medical cannabis coverage
When the federal government signed the Cannabis Act into law in 2018, legalizing recreational cannabis, it also committed to providing patients with better access to medical cannabis and to more extensively researching the trends, use patterns, patient impact, potential therapeutic treatments and adverse effects of cannabis and cannabinoids. The legislation also prompted new conversations in […]
- December 20, 2019 March 4, 2021
- 08:55